BioSpace News Archive

Dr. White previously held a related position at Alcon, a Novartis Company.

Amneal Pharmaceuticals, Inc. announced a 10-year license and supply agreement for Levothyroxine sodium tablets with Jerome Stevens Pharmaceuticals, Inc. (JSP), a New York-based pharmaceutical manufacturer of prescription tablet and capsule formulations. The agreement is effective March 22, 2019.

Findings support continued development of small-molecule NLRP3 antagonists for treatment of inflammatory diseases

The Canadian Medical Protective Association (CMPA) will host its Annual Meeting and Information Session on Wednesday, August 22, 2018 in Winnipeg, Manitoba. The theme of this year’s Information Session is “Healthier physicians: An investment in safe medical care.”

Continues Collaboration to Provide Regulatory Submission Support for Additional Patisiran Submissions

ChineseInvestors.com, Inc. announced that its wholly owned foreign enterprise, CBD Biotechnology Co. Ltd. (“CBD Biotech”), has launched a two-tier, direct selling initiative to accelerate its CBD sales into China.

Evoke Group announces the creation of a new singular global agency brand - Evoke - comprised of the complementary agencies and services within the group.

Connected Health Summit features panels on emerging connected health technology

Partnership will provide free hormonal IUDs to underserved women across the country

PANTHERx® Specialty Pharmacy, The Rare Disease Specialty Pharmacy®, announces that it has been named to the 37th Annual Inc. 5000 list, recognizing the fastest-growing private companies in America. PANTHERx® is being recognized on this prestigious national list as the 49th fastest growing company overall and the 5th fastest growing company in Health.